Alzheimer's disease (AD) is developing into the single greatest healthcare challenge in the coming decades. The development of early and effective treatments that can prevent the pathological damage responsible for AD-related dementia is of utmost priority for healthcare authorities. The role of the APOE-ε4 genotype, which has been shown to increase an individual's risk of developing AD, is of central interest to this goal. Understanding the mechanism by which possession of this gene modulates brain function, leading to a predisposition towards AD is an active area of research. Functional connectivity (FC) is an excellent candidate for linking APOE-related differences in brain function to sites of AD pathology. Magnetoencephalography (MEG) ...
Alzheimer's disease (AD) is the most common dementia with dramatic consequences. The research in str...
There is a well-established association between APOE genotype and the risk of developing Alzheimer's...
IMPORTANCE: Autosomal dominant Alzheimer disease (ADAD) is caused by rare genetic mutations in 3 spe...
The Apolipoprotein E (APOE) ε4 allele is the best-established genetic risk factor for sporadic Alzhe...
Alzheimer's disease (AD) is accompanied by functional brain changes that can be detected in imaging ...
The investigation of resting-state functional connectivity (rsFC) in asymptomatic individuals at gen...
BACKGROUND: The apolipoprotein E epsilon 4 (APOE-4) is associated with a genetic vulnerability to Al...
Background: The apolipoprotein E epsilon 4 (APOE-4) is associated with a genetic vulnerability to Al...
In this study, we used resting-state functional magnetic resonance imaging (fMRI) scans from subject...
We applied resting-state functional magnetic resonance imaging (fMRI) to examine the Apolipoprotein ...
Whole-brain structural and functional connectivity networks can be assessed using diffusion-weighted...
Structural and functional alterations of the brain in persons genetically at-risk for Alzheimer's di...
The presence of both apolipoprotein E (APOE) ε4 allele and amnestic mild cognitive impairment (aMCI)...
Drugs developed to slow, halt or reverse the progression of Alzheimer’s Disease (AD) have failed to ...
IMPORTANCE: Autosomal dominant Alzheimer disease (ADAD) is caused by rare genetic mutations in 3 spe...
Alzheimer's disease (AD) is the most common dementia with dramatic consequences. The research in str...
There is a well-established association between APOE genotype and the risk of developing Alzheimer's...
IMPORTANCE: Autosomal dominant Alzheimer disease (ADAD) is caused by rare genetic mutations in 3 spe...
The Apolipoprotein E (APOE) ε4 allele is the best-established genetic risk factor for sporadic Alzhe...
Alzheimer's disease (AD) is accompanied by functional brain changes that can be detected in imaging ...
The investigation of resting-state functional connectivity (rsFC) in asymptomatic individuals at gen...
BACKGROUND: The apolipoprotein E epsilon 4 (APOE-4) is associated with a genetic vulnerability to Al...
Background: The apolipoprotein E epsilon 4 (APOE-4) is associated with a genetic vulnerability to Al...
In this study, we used resting-state functional magnetic resonance imaging (fMRI) scans from subject...
We applied resting-state functional magnetic resonance imaging (fMRI) to examine the Apolipoprotein ...
Whole-brain structural and functional connectivity networks can be assessed using diffusion-weighted...
Structural and functional alterations of the brain in persons genetically at-risk for Alzheimer's di...
The presence of both apolipoprotein E (APOE) ε4 allele and amnestic mild cognitive impairment (aMCI)...
Drugs developed to slow, halt or reverse the progression of Alzheimer’s Disease (AD) have failed to ...
IMPORTANCE: Autosomal dominant Alzheimer disease (ADAD) is caused by rare genetic mutations in 3 spe...
Alzheimer's disease (AD) is the most common dementia with dramatic consequences. The research in str...
There is a well-established association between APOE genotype and the risk of developing Alzheimer's...
IMPORTANCE: Autosomal dominant Alzheimer disease (ADAD) is caused by rare genetic mutations in 3 spe...